LF
GILD icon

Lantz Financial’s Gilead Sciences GILD Stock Holding History

Lantz Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
16,595
-149
-0.9% -$19.6K 0.38% 72
2026
Q1 		$2.33M Sell
16,744
-1,933
-10% -$271K 0.48% 56
2025
Q4 		$2.29M Sell
18,677
-1,796
-9% -$218K 0.48% 54
2025
Q3 		$2.27M Sell
20,473
-513
-2% -$58.3K 0.5% 55
2025
Q2 		$2.33M Sell
20,986
-1,247
-6% -$133K 0.58% 46
2025
Q1 		$2.49M Sell
22,233
-3,367
-13% -$347K 0.68% 38
2024
Q4 		$2.36M Sell
25,600
-214
-0.8% -$19.3K 0.63% 44
2024
Q3 		$2.16M Buy
25,814
+894
+4% +$68.2K 0.59% 49
2024
Q2 		$1.71M Buy
24,920
+840
+3% +$56.1K 0.53% 58
2024
Q1 		$1.76M Buy
24,080
+1,470
+7% +$113K 0.57% 56
2023
Q4 		$1.83M Buy
22,610
+705
+3% +$54.9K 0.66% 45
2023
Q3 		$1.64M Sell
21,905
-218
-1% -$16.8K 0.65% 42
2023
Q2 		$1.71M Sell
22,123
-1,004
-4% -$80.1K 0.67% 43
2023
Q1 		$1.92M Sell
23,127
-2,711
-10% -$225K 0.8% 30
2022
Q4 		$2.22M Sell
25,838
-702
-3% -$55.6K 1.01% 23
2022
Q3 		$1.64M Buy
26,540
+220
+0.8% +$13.9K 0.85% 29
2022
Q2 		$1.63M Buy
26,320
+448
+2% +$27.7K 0.73% 31
2022
Q1 		$1.54M Buy
25,872
+2,409
+10% +$154K 0.63% 47
2021
Q4 		$1.7M Buy
23,463
+945
+4% +$65.1K 0.78% 37
2021
Q3 		$1.57M Buy
22,518
+539
+2% +$37.9K 0.81% 36
2021
Q2 		$1.51M Buy
21,979
+706
+3% +$47.1K 0.78% 38
2021
Q1 		$1.38M Buy
21,273
+770
+4% +$49.7K 0.78% 40
2020
Q4 		$1.2M Buy
20,503
+390
+2% +$23.5K 0.75% 39
2020
Q3 		$1.27M Buy
20,113
+846
+4% +$58.7K 0.85% 36
2020
Q2 		$1.48M Sell
19,267
-2,610
-12% -$200K 1.07% 27
2020
Q1 		$1.64M Buy
21,877
+4,352
+25% +$301K 1.28% 12
2019
Q4 		$1.14M Sell
17,525
-3,320
-16% -$216K 0.67% 50
2019
Q3 		$1.28M Buy
20,845
+1,095
+6% +$71.6K 0.87% 38
2019
Q2 		$1.36M Buy
19,750
+85
+0.4% +$5.59K 0.92% 35
2019
Q1 		$1.28M Buy
+19,665
New +$1.31M 0.93% 36

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Lantz Financial's GILD Position: Q2 2026 in Review

Lantz Financial reduced its Gilead Sciences (GILD) stake by 0.89% in Q2 2026, selling an estimated $19.6K and leaving 16,595 shares worth $2.1M. The position accounts for 0.38% of the portfolio, ranked #72.

Lantz Financial first reported a position in GILD in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.49M in Q1 2025. 486 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lantz Financial held 16,595 shares of Gilead Sciences worth $2.1M as of Q2 2026.
  • Lantz Financial sold 149 Gilead Sciences shares in Q2 2026, an estimated $19.6K.
  • Gilead Sciences made up 0.38% of Lantz Financial's portfolio in Q2 2026, its #72 holding.
  • Lantz Financial first reported a position in Gilead Sciences in Q1 2019 and has held it in 30 quarters since.
  • Lantz Financial's Gilead Sciences position peaked at $2.49M in Q1 2025.
  • 486 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.